Salidroside Reduces PDE2A Expression by Down-regulating p53 in Human Embryonic Lung Fibroblasts

Biomed Environ Sci. 2019 Feb;32(2):140-143. doi: 10.3967/bes2019.020.
No abstract available

MeSH terms

  • Cells, Cultured
  • Cyclic Nucleotide Phosphodiesterases, Type 2 / antagonists & inhibitors*
  • Cyclic Nucleotide Phosphodiesterases, Type 2 / metabolism
  • Fibroblasts / drug effects*
  • Fibroblasts / metabolism
  • Glucosides / pharmacology*
  • Humans
  • Lung / cytology
  • Lung / embryology
  • Phenols / pharmacology*
  • Phosphodiesterase Inhibitors / pharmacology*
  • Tumor Suppressor Protein p53 / metabolism*

Substances

  • Glucosides
  • Phenols
  • Phosphodiesterase Inhibitors
  • Tumor Suppressor Protein p53
  • Cyclic Nucleotide Phosphodiesterases, Type 2
  • PDE2A protein, human
  • rhodioloside